Skip to main content
TempraMed Technologies logo

TempraMed Technologies — Investor Relations & Filings

Ticker · VIVI ISIN · CA88024B1022 LEI · 529900AK4AXUNXYDWH07 CSE Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-09-19 Regulatory Filings
Country CA Canada
Listing CSE VIVI

About TempraMed Technologies

https://tempramed.com

TempraMed Technologies Ltd. develops and markets innovative, temperature-controlled storage solutions for injectable and temperature-sensitive pharmaceuticals, focusing on "last mile" control management for patients and healthcare providers. The company utilizes patented, space-grade insulation technology in its FDA-registered medical devices. Key products include the VIVI Cap, a thermal carrying case for insulin pens and weight loss medications, and the VIVI Epi, a temperature shield for epinephrine auto-injectors (EpiPen). These compact, maintenance-free solutions require no batteries or charging, ensuring medications remain within optimal temperature ranges 24/7/365, thereby safeguarding drug efficacy and minimizing the risk of spoilage due to temperature extremes.

Recent filings

Filing Released Lang Actions
Certificate and articles of change of name.pdf
Regulatory Filings Classification · 1% confidence The document is a provincial government issued Certificate of Change of Name under the British Columbia Business Corporations Act. It is not a financial report (Annual, Interim, Earnings, etc.), nor an investor presentation, management change notice, or any M&A, financing, or governance disclosure category. It is a statutory registry filing that does not fit any specific category in the list, so it defaults to the general Regulatory Filings category (RNS).
2025-09-19 English
Receipt for Amendment to Preliminary Prospectus.pdf
Regulatory Filings Classification · 1% confidence The document is a receipt issued by the British Columbia Securities Commission acknowledging the filing of an amended and restated preliminary long form prospectus. It does not contain the prospectus itself, financial results, or dividend details, nor does it announce a board change, legal proceeding, or capital-raising terms. It is a regulatory acknowledgement of a filing and thus best fits the fallback category for miscellaneous regulatory announcements: RNS.
2025-07-31 English
Amendment to (or amended) preliminary long form prospectus - English.pdf
Capital/Financing Update Classification · 1% confidence The document is an amended and restated preliminary prospectus for the qualification and distribution of common shares, subscription receipts, warrants and contingent rights under securities laws. It details terms of convertible debentures, private placement subscription receipts, a share exchange transaction and new listing application – all of which are fundraising and capital structure changes. This is not a brief notice or standalone audit/annual report, but a full prospectus for a securities offering. This fits the “Capital/Financing Update” category.
2025-07-31 English
Preliminary Receipt.pdf
Regulatory Filings Classification · 1% confidence The document is a receipt from the British Columbia Securities Commission acknowledging a filed Preliminary Long Form Prospectus. It contains no financial results, governance details, or substantive report content—just a receipt acknowledgment. This falls under general regulatory announcements that don’t fit other specific categories.
2025-05-01 English
Report of exempt distribution (45-106F1).pdf
Capital/Financing Update Classification · 1% confidence The document is a detailed pricing supplement and prospectus supplement for a new debt securities offering (Bank of Montreal Callable Contingent Income Barrier Notes). It describes the key terms of the issuance, coupon structure, autocall features, maturity payment, issue size, dealer information, and tax considerations. This is not an earnings release, management discussion, or annual report but rather an offering document announcing a financing transaction. Under our taxonomy, announcements of new debt offerings and other capital‐raising activities fall under Capital/Financing Update (CAP).
2025-04-10 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form “Form 45-106F1 Report of Exempt Distribution,” detailing an exempt securities distribution. It is not an annual or quarterly financial report, earnings release, proxy or AGM material, nor a board or M&A announcement. It is a mandatory regulatory filing that does not fit the more specialized categories and thus falls under the general “Regulatory Filings” category.
2025-04-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.